Dent on drug maker's image

Published: 2006-07-10 06:55:00

Updated: 2006-07-10 06:55:00

Market watchers predict the impact of the data fabrication on domestic pharmaceutical industry is more serious than financial loss, as the Korea Food and Administration unveiled the second results of forged bioequivalence data.

Industry watchers said the government is also responsible for the...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK